Activities per year
- 23 results
Search results
-
Radioactive Metals in Nuclear Medicine
Thomas Mindt (Invited speaker)
8 Nov 2024Activity: Talks and presentations › Talk or oral contribution › Science to Science
-
Site-selectively functionalized Albumin with DFO*-maleimide for 89Zr-radiolabelling yields a metabolically stable nano-PET probe that enables late time-point imaging of tumors in a murine colorectal cancer model
Julia Kronberger (Speaker), Theresa Balber (Contributor), H. Schueffl (Contributor), R. Wahrmann (Contributor), Anja Federa (Contributor), Thomas Wanek (Contributor), Marie Brandt (Contributor), Markus Mitterhauser (Contributor), Christian Kowol (Contributor), Thomas Mindt (Contributor) & P. Heffeter (Contributor)
19 Sept 2024Activity: Talks and presentations › Talk or oral contribution › Science to Science
-
New Strategies for the Development of Metal-Based Radiopharmaceuticals for the Diagnosis and Therapy of Cancer
Thomas Mindt (Invited speaker)
6 May 2024Activity: Talks and presentations › Talk or oral contribution › Science to Science
-
Synthesis and Preclinical Evaluation of BOLD-100 Radiolabeled with Ruthenium-97/103
Thomas Mindt (Speaker)
18 Apr 2024Activity: Talks and presentations › Talk or oral contribution › Science to Science
-
Metabolically Stabilized Triazolo-Peptidomimetics for Improved Tumor-Targeting
Thomas Mindt (Invited speaker)
11 Feb 2024Activity: Talks and presentations › Talk or oral contribution › Science to Science
-
Radioactive Labeled Molecules for Diagnosis and Therapy of Cancer
Thomas Mindt (Invited speaker)
17 Jan 2024Activity: Talks and presentations › Talk or oral contribution › Science to Science
-
Evaluation of two albumin-targeting moieties as in situ binders in comparison to maleimide
Anja Federa (Speaker), H. Schueffl (Contributor), Alexander Kastner (Contributor), Julia Kronberger (Contributor), Bernhard Keppler (Contributor), Thomas Mindt (Contributor), P. Heffeter (Contributor) & Christian Kowol (Contributor)
3 Sept 2023Activity: Talks and presentations › Talk or oral contribution › Science to Science
-
Radiometal-Based Radiopharmaceuticals for Theranostic Approaches in Nuclear Medicine
Thomas L. Mindt (Keynote speaker)
19 Jun 2023Activity: Talks and presentations › Talk or oral contribution › Science to Science
-
Theranostic Approaches in Radiopharmaceutical Sciences
Thomas L. Mindt (Invited speaker)
14 Mar 2023Activity: Talks and presentations › Talk or oral contribution › Science to Science
-
Metabolically Stabilized Triazolo-Peptidomimetics for Tumor Targeting
Thomas Mindt (Speaker)
1 Dec 2022Activity: Talks and presentations › Talk or oral contribution › Science to Science
-
Radiolabeling of [89Zr]Zr-Atezolizumab for its clinical evaluation in patient stratification for PD-L1 immune checkpoint inhibition therapy
Julia Kronberger (Speaker), Thomas Mindt (Contributor), Elisabeth de Vries (Contributor) & Marie Brandt (Contributor)
12 May 2022Activity: Talks and presentations › Talk or oral contribution › Science to Science
-
Auger electron therapy for cancer treatment
Maximilian Anderla (Speaker) & Thomas Mindt (Contributor)
5 Nov 2021Activity: Talks and presentations › Talk or oral contribution › Science to Science
-
Peptide-based Radiotracers for PD-L1 PET imaging
Nedra Jouini (Speaker) & Thomas Mindt (Contributor)
5 Nov 2021Activity: Talks and presentations › Talk or oral contribution › Science to Science
-
Radiolabeling of [89Zr]Zr-Atezolizumab for its clinical evaluation in patient stratification for PD-L1 immune checkpoint inhibition therapy
Julia Kronberger (Speaker), E. de Vries (Contributor), Marie Brandt (Contributor) & Thomas Mindt (Contributor)
5 Nov 2021Activity: Talks and presentations › Talk or oral contribution › Science to Science
-
First-in-human brain imaging of the GluN2B-containing N-methyl-D-aspartate receptor with (R)-11C-Me-NB1 PET
Lucas Rischka (Speaker), Chrysoula Vraka (Contributor), Verena Pichler (Contributor), Sazan Rasul (Contributor), Lukas Nics (Contributor), Gregor Gryglewski (Contributor), Patricia A. Handschuh (Contributor), Matej Murgaš (Contributor), G. N. Godbersen (Contributor), Leo Silberbauer (Contributor), M. Unterholzner (Contributor), C. Wotawa (Contributor), A. Haider (Contributor), H. Ahmed (Contributor), Roger Schibli (Contributor), Thomas Mindt (Contributor), Markus Mitterhauser (Contributor), Wolfgang Wadsak (Contributor), A. Hahn (Contributor), Rupert Lanzenberger (Contributor), Markus Hacker (Contributor) & Simon M. Ametamey (Contributor)
20 Oct 2021Activity: Talks and presentations › Talk or oral contribution › Science to Science
-
Radioactive labeled molecules for diagnosis and therapy of diseases
Thomas Mindt (Invited speaker)
11 Oct 2021Activity: Talks and presentations › Talk or oral contribution › Science to Science
-
Of Emerging and Established Radiometals
Thomas Mindt (Invited speaker)
2021Activity: Talks and presentations › Talk or oral contribution › Science to Science
-
Development of Radiometal-Based Theranostics
Thomas Mindt (Invited speaker)
2021Activity: Talks and presentations › Talk or oral contribution › Science to Science
-
Radiometal-Labelled Peptides and Proteins for Diagnosis and Therapy in Nuclear Medicine
Thomas Mindt (Invited speaker)
2021Activity: Talks and presentations › Talk or oral contribution › Science to Science
-
Jährliche Tagung der Arbeitsgemeinschaft Radiopharmazie und Radiochemie
Thomas Mindt (Speaker)
22 Sept 2019Activity: Talks and presentations › Talk or oral contribution › Science to Science
-
Matching a Radiometal with a Suitable Chelator - A Case Study for 89Zr-ImmunoPET
Thomas Mindt (Speaker)
26 May 2019Activity: Talks and presentations › Talk or oral contribution › Science to Science
-
Zirkonium-89 für ImmunoPET in der Nuklearmedizin
Thomas Mindt (Speaker)
3 Feb 2019Activity: Talks and presentations › Talk or oral contribution › Science to Science
-
Metabolically Stable Triazolo Peptidomimetics for Improved Tumour Targeting
Thomas Mindt (Speaker)
13 Dec 2018Activity: Talks and presentations › Talk or oral contribution › Science to Science